NCT06731933View on ClinicalTrials.gov

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

PHASE2RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Squamous Cell Carcinoma
Interventions
DRUG

BVEC

The study drug will be administered by home nurse at Subjects home for the participants residing in US. No drug will be applied when at study site. The subjects enrolled in Bari, Italy will not be administered BVEC.

Trial Locations (2)

94063

RECRUITING

Stanford University, Redwood City

Unknown

RECRUITING

Azienda Ospedliero-Universitaia, Bari

All Listed Sponsors
collaborator

Epidermolysis Bullosa Research Partnership

OTHER_GOV

lead

Stanford University

OTHER